Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Available-for-sale securities, at fair value:
Fixed maturity securities (amortized cost: 2018 – $92,429; 2017 – $86,993)	$ 94,024	$ 94,840
Equity securities (cost: 2017 – $247)		246
Trading securities	1,950	1,620
Equity securities	99
Mortgage loans on real estate	13,260	10,762
Real estate	12	11
Policy loans	2,509	2,399
Derivative investments	1,107	915
Other investments	2,255	2,296
Total investments	115,216	113,089
Cash and invested cash	2,345	1,628
Deferred acquisition costs and value of business acquired	10,264	8,403
Premiums and fees receivable	570	396
Accrued investment income	1,119	1,078
Reinsurance recoverables	17,748	4,907
Funds withheld reinsurance assets	557	593
Goodwill	1,782	1,368
Other assets	15,713	6,082
Separate account assets	132,833	144,219
Total assets	298,147	281,763
Liabilities
Future contract benefits	34,648	22,887
Other contract holder funds	91,233	80,209
Short-term debt		450
Long-term debt	5,839	4,894
Reinsurance related embedded derivatives	3	57
Funds withheld reinsurance liabilities	1,740	1,761
Payables for collateral on investments	4,805	4,417
Other liabilities	12,696	5,547
Separate account liabilities	132,833	144,219
Total liabilities	283,797	264,441
Contingencies and Commitments (See Note 14)
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized
Common stock – 800,000,000 shares authorized; 205,862,760 and 218,090,114 shares issued and outstanding as of December 31, 2018, and December 31, 2017, respectively	5,392	5,693
Retained earnings	8,551	8,399
Accumulated other comprehensive income (loss)	407	3,230
Total stockholders' equity	14,350	17,322
Total liabilities and stockholders' equity	$ 298,147	$ 281,763